Home Articles List Article Information
Egyptian Journal of Orthopedic Research
Journal Archive
Volume Volume 5 (2025)
Volume Volume 4 (2023)
Volume Volume 3 (2022)
Volume Volume 2 (2021)
Volume Volume 1 (2020)
E Abdel-Wanis, M., Mohammed Aldhilan, M. (2023). MIGHT FENUGREEK SEED EXTRACT BE A PROPHYLACTIC THERAPY FROM OSTEOPOROSIS?. Egyptian Journal of Orthopedic Research, 4(2), 41-44. doi: 10.21608/ejor.2023.346400
Mohamed E Abdel-Wanis; Mansour Mohammed Aldhilan. "MIGHT FENUGREEK SEED EXTRACT BE A PROPHYLACTIC THERAPY FROM OSTEOPOROSIS?". Egyptian Journal of Orthopedic Research, 4, 2, 2023, 41-44. doi: 10.21608/ejor.2023.346400
E Abdel-Wanis, M., Mohammed Aldhilan, M. (2023). 'MIGHT FENUGREEK SEED EXTRACT BE A PROPHYLACTIC THERAPY FROM OSTEOPOROSIS?', Egyptian Journal of Orthopedic Research, 4(2), pp. 41-44. doi: 10.21608/ejor.2023.346400
E Abdel-Wanis, M., Mohammed Aldhilan, M. MIGHT FENUGREEK SEED EXTRACT BE A PROPHYLACTIC THERAPY FROM OSTEOPOROSIS?. Egyptian Journal of Orthopedic Research, 2023; 4(2): 41-44. doi: 10.21608/ejor.2023.346400

MIGHT FENUGREEK SEED EXTRACT BE A PROPHYLACTIC THERAPY FROM OSTEOPOROSIS?

Article 1, Volume 4, Issue 2, December 2023, Page 41-44  XML PDF (194.48 K)
Document Type: Review articles: systemic review of different literatures.
DOI: 10.21608/ejor.2023.346400
View on SCiNiTO View on SCiNiTO
Authors
Mohamed E Abdel-Wanis1; Mansour Mohammed Aldhilan2
1Orthopedic Department, Ar Rass General Hospital, Kingdom of Saudia Arabia. Orthopedic Department, Sohag Faculty of Medicine, Sohag, Egypt
2Orthopedic Department, Ar Rass General Hospital, Kingdom of Saudia Arabia
Abstract
Osteoporosis is a systemic bone disease characterized by reduced bone mass and the deterioration of bone microarchitecture leading to bone fragility and an increased risk of fractures. Fenugreek regulates osteogenic markers and upregulates osteoblast differentiation by stimulating extracellular calcium concentrations as well as osteoblast differentiation. Experimental studies have shown that it increases osteocalcin and bone morphogenic protein-2 (BMP-2) levels in treated cells. Fenugreek causes DNA damage of osteoclasts. Also, fenugreek steroidal saponins hinder osteoclastogenic bone resorption. Trigonelline, a known constituent of fenugreek seeds, showed significant improvement and prevent the progression of osteoporosis We conclude that fenugreek seed extract might be of benefit for prophylaxis from osteoporosis. However, a well-planned randomized controlled trial is needed to have level I evidence of its efficacy

Keywords
Osteoporosis; Fenugreek; Osteoclast; Osteoblast; bone resorption
Statistics
Article View: 265
PDF Download: 335